Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 370,131Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 84UNITED THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8653137

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

02

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8653137

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

03

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8658694

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

04

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8658694

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

05

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 7999007

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2029-03-29

blank

06

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8653137

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

07

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8658694

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

08

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 8658694

Drug Substance Claim :

Drug Product Claim :

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2028-09-05

blank

09

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 7999007

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2029-03-29

blank

10

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

TREPROSTINIL

US Patent Number : 7999007

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21272

Patent Use Code : U-1437

Delist Requested :

Patent Use Description : ADMINISTRATION OF REMO...

Patent Expiration Date : 2029-03-29

blank